Stronger pharmaceutical intermediates
"The prospects for the development of pharmaceutical intermediates in China remain highly promising," said experts at the second seminar on R&D progress and market outlook for pharmaceutical intermediates held in 2006. The event brought together industry leaders, researchers, and professionals from over 70 domestic pharmaceutical intermediate companies, including Wang Pushan from the SFDA Information Center, Professor Liao Qingjiang from the China Pharmaceutical University, and Deputy Director Tao Jianhong from the SFDA Institute of Southern Medicine and Economics.
One of the key insights shared by the experts was the impressive growth in the chemical raw material pharmaceutical sector. In 2005, the total output value reached 116.727 billion yuan, a year-on-year increase of 33.51%. Profits rose to 6.78 billion yuan, up 27.5%, while exports hit $7.903 billion, an increase of 27.55% compared to the previous year. These figures highlight the strong momentum of the industry and suggest that the pharmaceutical market will continue to drive demand for intermediates.
Over time, the production of pharmaceutical intermediates has shifted from pharmaceutical companies to specialized chemical firms, reflecting the deepening division of labor and technological advancements. Internationally, pharmaceutical intermediates have become a major segment within the global chemical industry. In China, most manufacturers are small private enterprises with limited capital, typically investing between millions to 12 million yuan. Despite this, the higher profit margins compared to general chemicals have attracted many small chemical companies to enter the field.
China’s pharmaceutical intermediate industry has made significant strides, with most required materials now produced domestically, and only a small portion needing import. The country's abundant resources and low raw material costs have enabled large-scale exports. Compared to APIs and finished drugs, intermediates face fewer export restrictions, making them more attractive for international buyers. Many U.S. and European pharmaceutical companies are now sourcing intermediates from developing countries due to cost and environmental considerations, presenting new opportunities for Chinese manufacturers.
However, environmental concerns are becoming a growing challenge. As the government intensifies its focus on sustainability, rising environmental compliance costs could impact the industry. Experts also highlighted the need for strategic adjustments, especially in the face of competition from India, which is rapidly gaining ground in the pharmaceutical sector.
China’s pharmaceutical intermediates industry should focus on selecting competitive products. Certain varieties such as sulfonamides, tetracyclines, and acetaminophen already hold significant global market shares. Anti-infective drugs, vitamins, and pain relievers dominate exports, accounting for over 90% of all API exports. As disease patterns evolve, new drug demands will emerge, creating fresh opportunities for intermediates.
Experts also emphasized the need to upgrade the export structure. While the industry is growing, it still faces challenges like low-value products, lack of intellectual property, and weak export channels. Improving quality, building certifications like cGMP and FDA, and enhancing information systems are critical steps forward.
In terms of core competitiveness, companies must focus on innovation, brand building, and long-term stability rather than short-term gains. Although state-owned enterprises dominate, private and foreign-funded firms are also expanding rapidly. However, most intermediates producers are still small and face intense competition in an unstructured market.
With foreign players eyeing the Chinese market, the industry needs to adapt quickly. The future looks bright, but success will depend on smart strategies, continuous improvement, and a clear vision for sustainable growth.
Tube Skimmer,Sludge Settling Tank Scraping Machine,Half Bridge Center Drive Mud Suction Dredger,Solid Liquid Separator Sludge Scraper
LOREN INDUSTRY CO., LIMITED , https://www.lorenenvirontech.com